SynOx Therapeutics Ltd
1 known investors
SynOx Therapeutics develops treatments for people with tenosynovial giant cell tumours (TGCT) and other macrophage-mediated diseases. It is a biopharmaceutical company focused on addressing unmet clinical needs in these conditions.